Author:
Raoult D,Gallais H,De Micco P,Casanova P
Abstract
We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference6 articles.
1. Mediterranean spotted fever: a comparative study of 227 cases;Font-Creus B.;Rev. Infect. Dis.,1985
2. Hoflken G. H. Lode C. Prinzing K. Borner and P. Koeppe. 1968. Pharmacokinetics of ciprofloxacin after oral and parenteral NOTES 607
3. La forme maligne de la fiRvre boutonneuse mdditerraneenne: 6 observations;Raoult D.;Nouv. Presse Med.,1983
4. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality of chicken embryos and plaque assay;Raoult D.;Antimicrob. Agents Chemother.,1986
5. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases;Raoult D.;Am. J. Trop. Med. Hyg.,1986
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献